Details of the Drug
General Information of Drug (ID: DMRDF8Z)
| Drug Name | 
                     Piridronic acid 
                 | 
            ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms | 
                                         
                        Piridronic acid; UNII-ADD4H8T3K9; ADD4H8T3K9; CHEMBL99369; 75755-07-6; NE-97221; (1-phosphono-2-pyridin-2-ylethyl)phosphonic acid; Acido piridronico; Acide piridronique; Acidum piridronicum; Piridronic acid [INN]; NE 97221; Acido piridronico [Spanish]; Acidum piridronicum [Latin]; Acide piridronique [French]; AC1L1NEH; AC1Q7DKX; (2-(2-Pyridyl)ethylidene)diphosphonic acid; SCHEMBL223779; GTPL3183; DTXSID50226652; ZINC1999562; BDBM50373096; NE97221; 2-(2-Pyridyl)ethylidine-1,1-bisphosphonate; Phosphonic acid, (2-(2-pyridinyl)ethylide
                        
                     
                                     | 
            ||||||||||||||||||||||
| Indication | 
                                                            
  | 
            ||||||||||||||||||||||
| Drug Type | 
                     Small molecular drug 
                 | 
            ||||||||||||||||||||||
| Structure | 
                    ![]()  | 
            ||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 1 | Molecular Weight (mw) | 267.11 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient (xlogp) | -2.3 | ||||||||||||||||||||||
| Rotatable Bond Count (rotbonds) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count (hbonddonor) | 4 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count (hbondacc) | 7 | ||||||||||||||||||||||
| Chemical Identifiers | 
                        
  | 
                ||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT)  | 
                
                    
  | 
            ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
                    
  | 
            ||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References


